SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-07-000072
Filing Date
2007-01-04
Accepted
2007-01-04 16:17:18
Documents
1
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 3959
  Complete submission text file 0001005477-07-000072.txt   5963
Mailing Address 225 BELLEVILLE AVE 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
ALFACELL CORP (Issuer) CIK: 0000708717 (see all company filings)

IRS No.: 222369085 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VERTEX PHARMACEUTICALS INC 130 WAVERLY ST CAMBRIDGE MA 02139
Business Address ALFACELL CORP 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 2017488082
CONKLIN DONALD R (Reporting) CIK: 0001023202 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-11088 | Film No.: 07509621